Protagenic Therapeutics

Advertisement

cGxPJobs Banner

Protagenic Therapeutics Faces Nasdaq Delisting After Dual Compliance Failures

NEW YORK, NY — November 27, 2025: Protagenic Therapeutics, Inc., a clinical-stage biopharmaceutical company, has announced receipt of a...

By cGxPwire Editor
November 27, 2025

Read More

Advertisement

cGxPJobs

Directory